DEVELOPMENT OF A 4-AMINOPYRAZOLO[3,4-D]PYRIMIDINE-BASED DUAL IGF1R/SRC INHIBITOR AS A NOVEL ANTICANCER AGENT WITH MINIMAL TOXICITY

Account has been disabled due to a violation of Terms of Service. Contact Moderators

Account has been disabled due to a violation of Terms of Service. Contact Moderators

Blog Article

Report this page